A case of Methimazole-Induced Cholestatic Jaundice With Agranulocytosis / 대한내분비학회지
Journal of Korean Society of Endocrinology
;
: 519-523, 2005.
Article
in Korean
| WPRIM
| ID: wpr-115699
ABSTRACT
Methimazole is a widely used and generally well-tolerated antithyroid agent. Adverse reactions occur in 1~5% of patients taking methimazole medication, but these are most commonly transient, benign leukopenia and a skin rash. Severe cholestatic jaundice, combined with agranulocytosis, has been known as a rare complication. Herein, a case of methimazole induced cholestatic jaundice, with agranulocytosis, is reported.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Jaundice, Obstructive
/
Agranulocytosis
/
Exanthema
/
Leukopenia
/
Methimazole
Limits:
Humans
Language:
Korean
Journal:
Journal of Korean Society of Endocrinology
Year:
2005
Type:
Article
Similar
MEDLINE
...
LILACS
LIS